Trevi Therapeutics, Inc.
Index- P/E- EPS (ttm)-1.54 Insider Own3.05% Shs Outstand30.81M Perf Week13.13%
Market Cap80.37M Forward P/E- EPS next Y-0.93 Insider Trans- Shs Float10.68M Perf Month-33.13%
Income-33.90M PEG- EPS next Q-0.20 Inst Own46.90% Short Float3.72% Perf Quarter335.71%
Sales- P/S- EPS this Y18.10% Inst Trans29.24% Short Ratio0.32 Perf Half Y111.32%
Book/sh0.34 P/B6.59 EPS next Y-0.60% ROA- Target Price8.67 Perf Year11.50%
Cash/sh0.81 P/C2.76 EPS next 5Y- ROE- 52W Range0.46 - 3.73 Perf YTD186.37%
Dividend- P/FCF- EPS past 5Y-27.90% ROI- 52W High-39.97% Beta-
Dividend %- Quick Ratio2.30 Sales past 5Y- Gross Margin- 52W Low386.96% ATR0.27
Employees24 Current Ratio2.30 Sales Q/Q- Oper. Margin- RSI (14)45.26 Volatility8.99% 10.30%
OptionableNo Debt/Eq1.35 EPS Q/Q- Profit Margin- Rel Volume0.08 Prev Close2.24
ShortableYes LT Debt/Eq0.68 EarningsMay 12 AMC Payout- Avg Volume1.23M Price2.24
Recom1.50 SMA20-13.86% SMA50-4.29% SMA20057.66% Volume99,804 Change0.00%
Jun-03-19Initiated SVB Leerink Outperform $14
Jun-03-19Initiated Stifel Buy $20
Jun-03-19Initiated Needham Buy $18
Jun-03-19Initiated BMO Capital Markets Outperform $15
May-12-22 04:05PM  
May-05-22 04:05PM  
May-03-22 07:30AM  
Apr-13-22 04:25PM  
Apr-11-22 08:00AM  
Apr-07-22 08:00AM  
Apr-05-22 04:25PM  
Mar-23-22 03:25PM  
Mar-22-22 07:30AM  
Mar-17-22 04:05PM  
Mar-15-22 07:30AM  
Mar-09-22 04:05PM  
Feb-24-22 07:55AM  
Feb-01-22 07:30AM  
Jan-25-22 10:00AM  
Jan-05-22 07:00AM  
Dec-16-21 04:05PM  
Dec-01-21 08:22AM  
Nov-18-21 10:21AM  
Nov-15-21 07:30AM  
Nov-10-21 04:05PM  
Nov-09-21 07:30AM  
Nov-03-21 04:05PM  
Oct-13-21 04:05PM  
Oct-12-21 05:01AM  
Oct-11-21 07:01AM  
Oct-07-21 04:05PM  
Sep-30-21 06:57PM  
Aug-12-21 04:05PM  
Aug-09-21 04:05PM  
Aug-05-21 04:05PM  
Jun-09-21 07:30AM  
May-13-21 04:05PM  
May-06-21 04:05PM  
Apr-07-21 07:30AM  
Mar-25-21 04:05PM  
Mar-18-21 04:05PM  
Feb-18-21 04:05PM  
Feb-03-21 07:30AM  
Feb-01-21 07:30AM  
Nov-11-20 04:05PM  
Nov-10-20 07:30AM  
Nov-04-20 04:05PM  
Nov-03-20 02:47PM  
Oct-31-20 08:00AM  
Oct-21-20 08:00AM  
Oct-13-20 04:05PM  
Sep-09-20 04:05PM  
Aug-13-20 04:05PM  
Aug-10-20 03:30PM  
Aug-06-20 04:05PM  
Aug-05-20 07:30AM  
Jul-13-20 07:30AM  
Jun-30-20 04:45PM  
Jun-17-20 04:05PM  
Jun-01-20 11:44AM  
May-29-20 04:05PM  
May-07-20 04:05PM  
Apr-08-20 04:05PM  
Mar-16-20 08:00AM  
Feb-20-20 04:05PM  
Feb-18-20 04:05PM  
Feb-07-20 02:27PM  
Dec-11-19 06:45AM  
Nov-14-19 04:05PM  
Nov-13-19 05:01PM  
Nov-08-19 12:08PM  
Sep-05-19 04:05PM  
Aug-12-19 04:05PM  
Aug-09-19 11:40AM  
Jun-13-19 04:09PM  
Jun-03-19 02:35PM  
May-07-19 01:22PM  
May-01-19 10:31AM  
Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, which is in Phase IIb/III clinical trial is an oral extended release formulation of nalbuphine that is used for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis, and levodopa-induced dyskinesia in patients with Parkinson's disease, as well as to treat chronic kidney disease-associated with pruritus. It has a license agreement with Endo Pharmaceuticals Inc. to develop and commercialize products incorporating nalbuphine hydrochloride in any formulation; and Rutgers to develop and commercialize products incorporating nalbuphine for any human or animal use. The company was incorporated in 2011 and is headquartered in New Haven, Connecticut.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
TPG GP A, LLC10% OwnerMay 02Sale2.706001,6204,800,849May 04 05:17 PM
TPG GP A, LLC10% OwnerApr 29Sale2.7516,16344,3854,801,449May 02 05:04 PM
TPG GP A, LLC10% OwnerApr 28Sale2.777,27120,1404,817,612May 02 05:04 PM
Walker Paul Edward10% OwnerApr 11Buy1.903,580,5266,802,99910,421,428Apr 13 05:29 PM
Sonsini Peter W.10% OwnerApr 11Buy1.903,580,5266,802,99910,421,428Apr 13 05:26 PM
SANDELL SCOTT D10% OwnerApr 11Buy1.903,580,5266,802,99910,421,428Apr 13 05:24 PM
Makhzoumi Mohamad10% OwnerApr 11Buy1.903,580,5266,802,99910,421,428Apr 13 05:21 PM
Florence Anthony A. Jr.10% OwnerApr 11Buy1.903,580,5266,802,99910,421,428Apr 13 05:18 PM
Chang Carmen10% OwnerApr 11Buy1.903,580,5266,802,99910,421,428Apr 13 05:13 PM
Behbahani Ali10% OwnerApr 11Buy1.903,580,5266,802,99910,421,428Apr 13 05:10 PM
BASKETT FOREST10% OwnerApr 11Buy1.902,631,5784,999,99810,421,428Apr 13 05:04 PM
New Enterprise Associates 16, 10% OwnerApr 11Buy1.902,631,5784,999,99810,421,428Apr 13 05:00 PM